Fiche publication
Date publication
juillet 2024
Journal
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
Auteurs
Membres identifiés du Cancéropôle Est :
Pr VERGER Antoine
Tous les auteurs :
Boursier C, Zaragori T, Imbert L, Verger A
Lien Pubmed
Résumé
Few therapeutic options are currently available for refractory meningiomas. Encouraging results have been reported for Lu-labeled somatostatin receptor-targeted radiopeptide therapy (SSTR-RT). The current therapeutic scheme is based on the fixed doses that are recommended for neuroendocrine tumor treatment. However, in personalized medicine, tumor dosimetry can be determined from repeat Lu scintigraphy. The aim of this review was to report on the methods used for calculating the tumor absorbed dose (AD) in meningioma patients treated with Lu-SSTR-RT and their values.
Référence
Q J Nucl Med Mol Imaging. 2024 07 19;:
